These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thalidomide and sensory neurotoxicity: a neurophysiological study. Zara G; Ermani M; Rondinone R; Arienti S; Doria A J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1258-61. PubMed ID: 18450790 [TBL] [Abstract][Full Text] [Related]
3. Neuropathy in multiple myeloma treated with thalidomide: a prospective study. Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676 [TBL] [Abstract][Full Text] [Related]
4. Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy. Kocer B; Sucak G; Kuruoglu R; Aki Z; Haznedar R; Erdogmus NI Acta Neurol Belg; 2009 Jun; 109(2):120-6. PubMed ID: 19681443 [TBL] [Abstract][Full Text] [Related]
5. Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus. Briani C; Zara G; Rondinone R; Della Libera S; Ermani M; Ruggero S; Ghirardello A; Zampieri S; Doria A Neurology; 2004 Jun; 62(12):2288-90. PubMed ID: 15210897 [TBL] [Abstract][Full Text] [Related]
6. [Thalidomide-induced sensory neuropaty in patients with multiple myeloma]. Bilińska M; Usnarska-Zubkiewicz L; Szymczyk M; Noga L; Potoczek S; Kuliczkowski K; Podemski R Pol Merkur Lekarski; 2011 Aug; 31(182):86-91. PubMed ID: 21936343 [TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic changes in thalidomide neuropathy in the treatment of discoid lupus erythematosus]. Ludolph A; Matz DR EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Dec; 13(4):167-70. PubMed ID: 6295739 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal Patterns of Thalidomide Neuropathy in Children and Adolescents. Liew WK; Pacak CA; Visyak N; Darras BT; Bousvaros A; Kang PB J Pediatr; 2016 Nov; 178():227-232. PubMed ID: 27567409 [TBL] [Abstract][Full Text] [Related]
12. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children. Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061 [TBL] [Abstract][Full Text] [Related]
13. [Unmyelinated nerve fibers in senile nerves and in late thalidomide neuropathy: a quantitative electron microscopic study (author's transl)]. Schröder JM; Gibbels E Acta Neuropathol; 1977 Aug; 39(3):271-80. PubMed ID: 906809 [TBL] [Abstract][Full Text] [Related]
16. [Neuropathies caused by thalidomide]. Chapon F; Lechevalier B; da Silva DC; Rivrain Y; Dupuy B; Deschamps P Rev Neurol (Paris); 1985; 141(11):719-28. PubMed ID: 3003871 [TBL] [Abstract][Full Text] [Related]
17. Lenalidomide long-term neurotoxicity: Clinical and neurophysiologic prospective study. Dalla Torre C; Zambello R; Cacciavillani M; Campagnolo M; Berno T; Salvalaggio A; De March E; Barilà G; Lico A; Lucchetta M; Ermani M; Briani C Neurology; 2016 Sep; 87(11):1161-6. PubMed ID: 27534712 [TBL] [Abstract][Full Text] [Related]
18. Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients. Coelho A; Souto MI; Cardoso CR; Salgado DR; Schmal TR; Waddington Cruz M; de Souza Papi JA Lupus; 2005; 14(6):434-9. PubMed ID: 16038106 [TBL] [Abstract][Full Text] [Related]